Genmab Announces CHMP Grants Accelerated Assessment for Daratumumab for Double Refractory Multiple Myeloma
September 25, 2015 at 05:25 AM EDT
Genmab A/S (OTC: GNMSF) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
